Clinical Trials in Atlanta

Showing 13041-13060 of 19,805 trials

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

NCT02143843

This study evaluates the long-term (13-months) safety of the Bimatoprost Ocular Insert in participants with Glaucoma or Ocular Hypertension who completed study FSV5-002. All participants received Bimatoprost Ocular Insert and wore it for approximately 7 months, then had the Insert removed and a new insert placed for another 6 months.

Primary Open-Angle GlaucomaOcular Hypertension

ForSight Vision5, Inc.75 participantsStarted Jun 2014

Artesia, California, United States • La Jolla, California, United States • Newport Beach, California, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

NCT00504556

This study is to assess the safety of a potential new drug DU-176b for the prevention of stroke/systemic embolic event (SEE) in individuals with non-valvular atrial fibrillation (AF). The duration is 3 months of treatment and a 30 day follow-up visit.

Atrial FibrillationThromboembolism

Daiichi Sankyo1,146 participantsStarted Jun 2007

Huntsville, Alabama, United States • Anaheim, California, United States • Beverly Hills, California, United States +88 more locations

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Find Trials by Condition in Atlanta

Adult Congenital Heart Disease Surgery

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)

Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

A Randomized Trial of Induction Versus Expectant Management

Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy

Veterans Individual Placement and Support Towards Advancing Recovery

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers

Heart Outcomes Prevention and Evaluation 4